Risk factors for microbiological persistence after 6 months of treatment for Mycobacterium intracellulare and its impact on the drug-resistance profile
ABSTRACT Patients with Mycobacterium intracellulare pulmonary disease are more likely to experience poor treatment outcomes if they have been observed with microbiological persistence after 6 months of treatment. This study aims to identify the risk factors for microbiological persistence and descri...
Main Authors: | Xuejiao Luo, Xubin Zheng, Yong Fang, Fangyou Yu, Haiyan Cui, Qin Sun, Wei Sha |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2023-10-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.00805-23 |
Similar Items
-
Prominent transcriptomic changes in Mycobacterium intracellulare under acidic and oxidative stress
by: Hyun-Eui Park, et al.
Published: (2024-04-01) -
In vitro synergic effect of ²-lapachone and isoniazid on the growth of Mycobacterium fortuitum and Mycobacterium smegmatis
by: Joas L da Silva, et al.
Published: (2009-07-01) -
A case of isolated pulmonary Mycobacterium avium complex infection in an immunocompetent host
by: Sivanthi Sapna Rajendran, et al.
Published: (2023-01-01) -
Bacteriophage infection and killing of intracellular Mycobacterium abscessus
by: Alan A. Schmalstig, et al.
Published: (2024-01-01) -
Virulence of Mycobacterium intracellulare clinical strains in a mouse model of lung infection – role of neutrophilic inflammation in disease severity
by: Yoshitaka Tateishi, et al.
Published: (2023-04-01)